Below is a roundup of latest news from South Africa's life sciences and healthcare industries, including a call to overhaul patent laws to allow better access to COVID-19 drugs, innovation for HIV and TB medication adherence, COVID-19 vaccine trials, gut…
With Africa struggling to vaccinate its populations against COVID-19, the World Bank – along with government institutions from the USA, Germany, and France – has intervened to loan South African…
Kelly Chibale, founder of the H3D Centre at the University of Cape Town and chairman & CEO of the H3D Foundation, outlines the rationale behind the establishment of these institutions,…
South African firm Aspen has inked a deal with Johnson & Johnson for the technical transfer and proposed commercial manufacture of their COVID-19 vaccine candidate, Ad26.COV2-S, boosting the company’s share…
Abbvie GM for South Africa Christo Kruger highlights the various types of projects that the Public Health Enhancement Fund (PHEF) is pursuing to help alleviate the country’s currently overburdened healthcare system. He also describes AbbVie’s role in this industry collective, and also depicts the company’s developing foothold within the South African market after its split from Abbott Laboratories in 2012. …
The minister of health reveals how for the first time in the country´s history the healthcare sector is following a clear roadmap with the National Development Plan, a vision for…
Ansie Savrda of ERS (pty) ltd, highlights the important role that ERS plays in helping pharmaceutical companies to efficiently navigate South Africa and Africa’s regulatory environment through the company’s broad portfolio of regulatory…
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when her oldest child was diagnosed with Pompe disease at 11…
As COVID-19 threatens to derail more than a decade’s worth of hard-won gains in the fight against malaria, Dr Benjamin Pretorius, managing director at ERADA Technology Alliance, warns that diversions…
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a Covid-19 drug, in South Africa this month. The company’s priority is ensuring access…
The latest from South African pharma, including President Ramaphosa’s blunt criticism of Big Pharma, Aspen’s reception of USD 700 million in international financial aid, Adcock Ingram’s disappointing results as fewer…
The global rush to secure access to COVID-19 vaccines has led to accusations that richer countries are hoarding supply at the expense of poorer nations. While some are calling for…
A roundup of the latest news from South African pharma, including Aspen’s impressive annual growth, Adcock Ingram’s full year profit drop, and Entos Pharma’s approval for Phase II clinical rials…
See our Cookie Privacy Policy Here